Loerrach, Germany

Max Klatte


Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
2 patents (USPTO):

Title: Max Klatte: Innovator in Bis-Tetrahydroisoquinoline-Containing Compounds

Introduction

Max Klatte is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of chemistry, particularly in the development of bis-tetrahydroisoquinoline-containing compounds. With a total of 2 patents to his name, Klatte's work is recognized for its potential applications in treating proliferative diseases.

Latest Patents

Klatte's latest patents focus on methods for preparing bis-tetrahydroisoquinoline-containing compounds, including (−)-Jorumycin, ecteinascidin 743, saframycin A, and related compounds. These patents detail the methods of preparing these compounds, formulations that comprise them, and innovative methods for treating proliferative diseases using these compounds.

Career Highlights

Max Klatte is affiliated with the California Institute of Technology, where he continues to advance his research and development efforts. His work has garnered attention in the scientific community for its potential impact on medical treatments.

Collaborations

Klatte has collaborated with esteemed colleagues such as Brian M Stoltz and Eric R Welin, contributing to a rich environment of innovation and discovery.

Conclusion

Max Klatte's contributions to the field of chemistry, particularly through his patents on bis-tetrahydroisoquinoline-containing compounds, highlight his role as a significant inventor. His ongoing work promises to influence future treatments for proliferative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…